Local pharmacy leaders from across the country met to discuss critical issues and consider ways to secure community pharmacy’s place in plans to develop the health service. The Annual Conference of LPC Representatives held last week considered important topics for the coming year with speakers sharing insights on the 10 Year Health Plan, healthcare networks,
Read moreThe following price concessions granted in November 2025 have rolled over to December 2025: Drug Pack size November 2025 price concession Carbocisteine 375mg capsules 120 £2.95 Pyridostigmine bromide 60mg tablets 200 £15.79 Repaglinide 1mg tablets 90 £31.73 Please note any rolled over prices can be adjusted upwards if we receive reports from pharmacy owners to
Read moreThe Department of Health and Social Care (DHSC) has today (03/12/2025) confirmed the following final list of price concessions for November 2025. Drug Pack size Price concession Amiodarone 200mg tablets 28 £5.99 Aripiprazole 2.5mg tablets 28 £31.14 Carbocisteine 375mg capsules 120 £2.95 Estriol 0.01% vaginal cream with applicator 1 £47.05 Pyridostigmine bromide 60mg tablets 200 £15.79 Repaglinide
Read moreAs part of our Funding & Reimbursement Shorts series, Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video on disallowed items. Disallowed items are those that have not been passed for payment by the NHS Business Services Authority (NHSBSA). It is important that pharmacy teams understand what can be done avoid
Read moreThe Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Rivastigmine 4.6mg/24hours transdermal patches Rivastigmine 9.5mg/24hours transdermal patches MSN/2025/062 Tier 3 – high impact Date of issue: 03/12/2025 Summary Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches are in limited supply until w/c 15 December 2025. Rivastigmine 13.3mg/24hours transdermal
Read moreBy Chief Executive Janet Morrison Late last month, the Community Pharmacy England Committee met to continue preparations for the upcoming CPCF negotiations and review long-term strategic priorities. We also welcomed new Committee members and were hugely grateful to all business owners who contributed evidence to us through recent polls and events. Key discussion areas included
Read moreCommunity Pharmacy England met in London on 19th and 20th November, with Committee members considering preparations for the next round of Community Pharmacy Contractual Framework (CPCF) negotiations, ongoing financial pressures, winter readiness and other important matters. Closing the sector’s longstanding funding gap and addressing operational pressures remain the central focus of the Committee. There has
Read moreAs part of Community Pharmacy England’s commitment to working more closely with pharmacy owners – listening to them better, as well as engaging more regularly via events and other channels – we sought input from the sector ahead of the November 2025 Committee Meeting. Between October 20th to November 10th, the latest sector opinion poll
Read moreCommunity Pharmacy England met in London for a full Committee meeting on 19th and 20th November 2025. Committee discussions focused on the upcoming CPCF negotiations: financial pressures remain a very serious concern, with closing the funding gap still the Committee’s top priority. The Committee also considered the additional pressures that winter is expected bring to
Read moreThe Department of Health and Social Care (DHSC) has today (28/11/2025) confirmed the following list of price concessions for November 2025: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the Department.
Read more
